Samuel J. Ridout, MD, PhD

The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, California

  • 4Articles
  • 36.6KReads
  • 2021–2026Active
  • 16Collaborators
  • 37Citations

About

Samuel J. Ridout, MD, PhD, is affiliated with The Permanente Medical Group, Kaiser Permanente Northern California, Oakland. Ridout has published extensively on topics including depression, anxiety, bipolar disorder, psychopharmacology, and patient care, with a focus on clinical characteristics, demographic factors, and treatment approaches. His work also addresses the impact of COVID-19 on mental health care and the intersection of substance use and medication levels. Ridout’s research has appeared in Psychiatrist.com from 2021 to 2026.

Publications

JCP
Race, Ethnicity, Socioeconomic Status, Clinical Characteristics, and Postpartum Depression in Patients with a History of Depressive Episodes
Original Research

Race, Ethnicity, Socioeconomic Status, Clinical Characteristics, and Postpartum Depression in Patients with a History of Depressive Episodes

June 17, 2026

Patients who were non-White and had lower incomes had higher PPD risk. Higher antidepressant dosing before pregnancy, stopping antidepressants during pregnancy, and moderate-severe symptoms early in pregnancy were associated...
, , , et al
JCP
Collaborative vs Specialty Care for Depression or Anxiety
Original Research

Collaborative vs Specialty Care for Depression or Anxiety

September 4, 2024

Model effects at 6 months revealed that patients assigned to collaborative care showed significantly greater improvement than those assigned to specialty psychiatry.
, , , et al
JCP
Case Report

Change in Blood Carbamazepine Levels With Cannabis Use

May 11, 2021

This report describes carbamazepine level fluctuations that occurred concurrent with stopping and restarting of cannabis use in a patient with bipolar disorder.
, ,
JCP
Original Research

COVID-19 and Mental Health Short title

March 3, 2021

This study sought to identify patients vulnerable to worsening mental health during the early COVID-19 pandemic. Read this article to learn about the dramatic changes in psychiatric care experienced...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe